Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Greenfield

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neuropharmacology|May 29, 2013
High-resolution spatio-temporal bioactivity of a novel peptide revealed by optical imaging in rat orbitofrontal cortex in vitro: possible implications for neurodegenerative diseasesAntoine-Scott Badin, John Eraifej, Susan Greenfield
International Journal of Molecular Sciences|November 27, 2024
Oxidative Stress Triggers a Pivotal Peptide Linked to Alzheimer's DiseaseNikki Evans, Kashif Mahfooz, Sara Garcia-Rates, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 16, 2018
Protective and reversal actions of a novel peptidomimetic against a pivotal toxin implicated in Alzheimer's diseaseGiovanni Ferrati, Georgi Bion, Andrew J Harris, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 15, 2022
Antagonising a novel toxin "T14" in Alzheimer's disease: Comparison of receptor blocker versus antibody effects in vitroSibah Hasan, Mehreen Ahmed, Sara Garcia-Ratés, et al.
Plos One|February 8, 2013
Additive toxicity of β-amyloid by a novel bioactive peptide in vitro: possible implications for Alzheimer's diseaseSara Garcia-Ratés, Matthew Lewis, Rosemary Worrall, et al.
International Journal of Molecular Sciences|December 17, 2024
A Novel 14mer Peptide Inhibits Autophagic Flux via Selective Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer's DiseaseCloe García Porta, Kashif Mahfooz, Joanna Komorowska, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 4, 2026
Therapeutic antagonism of a key toxin driving Alzheimer's disease: Comparison of a peptide variant and small moleculeCatalina Vigil Cardenal, Kashif Mahfooz, Sara Garcia-Rates, et al.
Oncotarget|January 13, 2017
Tumor cell migration is inhibited by a novel therapeutic strategy antagonizing the alpha-7 receptorChris Pepper, Henry Tu, Paul Morrill, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 15, 2023
Antagonism of a key peptide 'T14' driving neurodegeneration: Evaluation of a next generation therapeuticSanskar Ranglani, Sibah Hasan, Kashif Mahfooz, et al.
International Journal of Molecular Sciences|June 28, 2023
A Novel Bioactive Peptide, T14, Selectively Activates mTORC1 Signalling: Therapeutic Implications for Neurodegeneration and Other Rapamycin-Sensitive ApplicationsSanskar Ranglani, Anna Ashton, Kashif Mahfooz, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neuropharmacology|May 29, 2013
High-resolution spatio-temporal bioactivity of a novel peptide revealed by optical imaging in rat orbitofrontal cortex in vitro: possible implications for neurodegenerative diseasesAntoine-Scott Badin, John Eraifej, Susan Greenfield
International Journal of Molecular Sciences|November 27, 2024
Oxidative Stress Triggers a Pivotal Peptide Linked to Alzheimer's DiseaseNikki Evans, Kashif Mahfooz, Sara Garcia-Rates, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 16, 2018
Protective and reversal actions of a novel peptidomimetic against a pivotal toxin implicated in Alzheimer's diseaseGiovanni Ferrati, Georgi Bion, Andrew J Harris, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 15, 2022
Antagonising a novel toxin "T14" in Alzheimer's disease: Comparison of receptor blocker versus antibody effects in vitroSibah Hasan, Mehreen Ahmed, Sara Garcia-Ratés, et al.
Plos One|February 8, 2013
Additive toxicity of β-amyloid by a novel bioactive peptide in vitro: possible implications for Alzheimer's diseaseSara Garcia-Ratés, Matthew Lewis, Rosemary Worrall, et al.
International Journal of Molecular Sciences|December 17, 2024
A Novel 14mer Peptide Inhibits Autophagic Flux via Selective Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer's DiseaseCloe García Porta, Kashif Mahfooz, Joanna Komorowska, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 4, 2026
Therapeutic antagonism of a key toxin driving Alzheimer's disease: Comparison of a peptide variant and small moleculeCatalina Vigil Cardenal, Kashif Mahfooz, Sara Garcia-Rates, et al.
Oncotarget|January 13, 2017
Tumor cell migration is inhibited by a novel therapeutic strategy antagonizing the alpha-7 receptorChris Pepper, Henry Tu, Paul Morrill, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 15, 2023
Antagonism of a key peptide 'T14' driving neurodegeneration: Evaluation of a next generation therapeuticSanskar Ranglani, Sibah Hasan, Kashif Mahfooz, et al.
International Journal of Molecular Sciences|June 28, 2023
A Novel Bioactive Peptide, T14, Selectively Activates mTORC1 Signalling: Therapeutic Implications for Neurodegeneration and Other Rapamycin-Sensitive ApplicationsSanskar Ranglani, Anna Ashton, Kashif Mahfooz, et al.
Pageof 3